Address: Rua São Sebastião, 305 São Paulo, SP – Brasil CEP 04708 000,Brazil
Tel: (55-11) 5524-2430
Web: http://www.besins-healthcare.com/
As a global company, committed to innovation and high quality products, BESINS HEALTHCARE is a leader in different areas of expertise. These areas include women’s health – gynaecology, fertility & obstetrics as well as men’s health and nutrition.
BESINS HEALTHCARE headquarters are located in Brussels, Belgium. The company has gained international recognition and presence over the last 30 years through its subsidiaries and partnerships in more than 90 countries.
Besins entered Brazil in 2010, and plans to launch Androgel in 2012. Two products are already licensed to Farmoquimica: a progesterone named Utrogestan, which is the number one product of the company, and the worldwide unique natural micronized progesterone and oestogel, Natural Estradiol using Transdermal Delivery Technology. Utrogestan is the market leader of progesterone in Brazil.
Utrogestan, Oestrogel, Androgel
Besins finally arrived in Brazil in 2010. In addition to introducing the company to the market, would you also elaborate on the strategic motivation behind this decision? Besins Healthcare is…
Pius Hornstein, MSc, PhD, country chair Sanofi Brazil and general manager Pharma, shares his positive outlook on the Brazilian pharma market over the next few years and details Sanofi’s strategy…
Laurena de Almeida Magnoni, regional director for Latin America at Besins Healthcare, a pharmaceutical company specialized in the development and worldwide diffusion of innovative drugs and food supplements for men’s…
Norberto Prestes, director of the Brazilian Pharmochemicals Manufacturers Association (ABIQUIFI), provides insights into the main dynamics that have been shaping Brazil’s pharmaceutical and API sectors over the past few years,…
Ricardo Lourenço, VP-Managing Director of Lupin in Brazil has been in charge of implementing the take over of Medquímica by Lupin. In this interview he explains Brazil is a land…
Josiel Florenzano, managing director of Lundbeck Brazil and South Cone, provides us with an overview of the main dynamics shaping the Brazilian CNS market as well as the opportunities he…
Neide Kawabata, president of B Braun Brazil, shares B Braun’s long track record of success and commitment to Brazil, the innovations they continue to bring to the market, and the…
Dr. Ogari Pacheco, president of the Board of Directors for Cristália, highlights the unique journey for Cristália over the past 45 years, as one of the most innovative local pharma…
Andrew Simpson, Scientific Director of Orygen, elaborates on the innovative collaboration model his company is taking part in to develop biotechnologies in Brazil, the importance of developing affordable treatments for…
Jaime Rabi, director of Microbiológica, documents the unique development path of the company and its pioneering contribution to the production of antiretroviral medicines in Brazil, as well as its international…
Heraldo Marchezini, CEO of the Brazilian biotech company Biomm and one of the leading executives in the Brazilian biopharmaceutical sector, provides insights into the eye-catching international partnerships recently signed by…
Marco Fireman, vice-minister and chairman of the National Commission for the Incorporation of Technologies (CONITEC); a board that advises the Brazilian Ministry of Health on the inclusion of new health…
Samuel Mauricio, vice-president for Brazil at Octapharma, one of the largest human protein manufacturers in the world, provides an insightful analysis of the Brazilian plasma market, demonstrating Octapharma’s remarkable willingness…
See our Cookie Privacy Policy Here
